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Abstract
Purpose
To assess the level of medication adherence and to investigate predictors of medication
adherence and blood pressure control among hypertensive patients attending primary
healthcare clinics in Makkah, Saudi Arabia.
Patients and methods
Hypertensive patients meeting the eligibility criteria were recruited from eight primary care
clinics between January and May 2016 for this study. The patients completed Arabic version
of Morisky Medication Adherence Scale (MMAS-8), an eight-item validated, self-reported
measure to assess medication adherence. A structured data collection form was used to
record patients’ sociodemographic, medical and medication data.
Results
Two hundred and four patients, of which 71.6% were females, participated in the study.
Patients’ mean age was 59.1 (SD 12.2). The mean number of medication used by patients
was 4.4 (SD 1.89). More than half (110; 54%) of the patients were non-adherent to their
medications (MMAS score < 6). Binary regression analysis showed that highly adherent
patients (MMAS score = 8) were about five times (OR 4.91 [95%CI: 1.85–12.93; P = 0.01])
more likely to have controlled blood pressure compared to low adherent patients. Female
gender (OR 0.40 [95% CI: 0.20–0.80; P = 0.01]), Age > 65 years (OR 2.0 [95% CI: 1.0–4.2;
P = 0.04]), and being diabetic (OR 0.25 [95% CI: 0.1–0.6; P = 0.04]) were found to be inde-
pendent predictors of medication adherence.
Conclusion
Medication adherence is alarmingly low among hypertensive patients attending primary
care clinics in Saudi Arabia which may partly explain observed poor blood pressure control.
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There is a clear need to educate patients about the importance of medication adherence
and its impact on improving clinical outcomes. Future research should identify barriers to
medication adherence among Saudi hypertensive patients.
Introduction
Globally, hypertension is a serious public health problem as it is one of the leading preventable
causes of morbidity and mortality [1, 2]. As of 2008, the World Health Organization (WHO)
reported that hypertension affected 1 billion patients across the globe, 40% of adults aged 25
years and above. Hypertension accounts for 9.4 million deaths every year either due to heart
diseases (45%) or stroke (51%) worldwide [1]. Given the high humanistic and economic cost
associated with hypertension, early detection, proper management and control of blood pres-
sure is crucial to avoid long term complications of hypertension [2].
Pharmacotherapy together with lifestyle modifications remain the cornerstone in the manage-
ment of hypertension [3, 4]. Medication adherence is the key in achieving the desired clinical out-
comes [5]. The WHO defines medication adherence as “the extent to which a person’s behavior—
taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed
recommendations from a health care provider” [5]. A number of studies conducted internation-
ally have reported significant association between medication adherence and blood pressure con-
trol [6–12]. Poor medication adherence is associated with various medical/psychosocial
complications, poorer health-related quality of life and increased the health care costs [5, 13, 14].
In Saudi Arabia, hypertension has been estimated to be the leading risk factor for death [15]. It
has been estimated that about one in four adults (age 15–64 years) have hypertension [16]. Poor
blood pressure control among Saudi patients is well documented [16,17]. A large national study
reported that 63% (total N = 1213) of the hypertensive patients had uncontrolled blood pressure,
an alarmingly high rate [16]. However, there is scarcity of data regarding Saudi patients’ adher-
ence to antihypertensive medications, especially within primary care setting [18–20]. Since hyper-
tension is primarily managed within primary care, it is important to assess the level of medication
adherence and factors affecting adherence, so that necessary measures can be taken within the pri-
mary care settings in order to improve patients’ adherence to their medications, prevent long-
term negative consequences of non-adherence and reduce burden on secondary care.
The main objectives of the current study were to: (1) assess the level of medication adher-
ence in adult hypertensive patients attending primary care clinics; (2) identify socio-demo-
graphic and clinical characteristics that affect patients’ adherence and blood pressure control.
Material and Methods
Ethical approval
The study was approved by the local Institutional Review Board (IRB) at the Faculty of Phar-
macy, Umm Al-Qura University, Makkah, Saudi Arabia. In addition, ethics and governance
approval were also obtained from the General Directorate of Health Affairs Makkah Region,
Ministry of Health, Saudi Arabia (Ref # M/47/402/2334855). Each participant completed a
written consent form before enrollment.
Participants and settings
This was a prospective cross-sectional study conducted between January and May 2016.
Patients’ data were collected from eight different primary healthcare clinics (PHC) in Makkah
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city. Convenient sampling technique was used to recruit these clinics. Patients meeting the fol-
lowing inclusion and exclusion criteria were included: confirmed diagnosis of hypertension
for more than 6 months; Age> 18 years; taking at least one antihypertensive medication; and
ability to communicate in Arabic. Pregnant women, patients with mental health issues and
dementia were excluded from the study. The attending general physician (GP) screened all
patients during the study period and assessed for eligibility.
A universal sampling techniques was used to recruit the patients. All patients meeting inclu-
sion and exclusion criteria were requested to participate in the study and were asked to com-
plete a written consent form. For the purpose of this study, the goal of controlled blood
pressure (BP) was defined in accordance to the NICE guideline (2011) for hypertension in
adult patients [2]. Patients’ blood pressure was considered controlled if: (1) Patients under 80
years old with treated hypertension have BP under 140/90 mmHg. (2) Patients aged 80 years
or over with treated hypertension have BP under 150/90 mmHg. (3) Patients with both hyper-
tension and diabetes mellitus have BP less than 140/80 mmHg or less than 130/80 mmHg (in
presence of any kidney, eye or cerebrovascular damage).
Data collection
For assessing medication adherence, patients were requested to complete a structured and vali-
dated 8-item questionnaire, Morisky Medication Adherence Scale (MMAS-8) [21–23]. Since
Arabic is the national language of Saudi Arabia, a validated Arabic translated version of
MMAS-8 was used in this study. MMAS-8 has been widely used for assessing patients’ adher-
ence to their medications [6–8, 24–27].
The first seven items of MMAS-8 have dichotomous responses (Yes/No) to avoid acquies-
cence bias, whereas the eighth item has 5-point Likert scale response indicating low to high
level of adherence [21–23]. Total summated adherence score range between 0 and 8. Using the
standard scoring criteria, a score less than 6 was considered low adherence, between 6 and less
than 8 as medium adherence and 8 as high adherence. A license agreement was signed and
permission was obtained from appropriate authority to use MMAS-8 in this study [21–23].
A standardized, structured data collection form was used to gather patients’ sociodemo-
graphic, medical and medication data. The respective attending physician completed this form
by reviewing patients’ medical record.
Statistical analysis
Statistical analyses were conducted by SPSS software (Version 23.0. Armonk, NY: IBM Corp).
All statistical tests used were two-tailed. The alpha level of significance for all statistical tests
was 0.05 unless otherwise specified. Binary logistic regression analysis using the backward
stepwise likelihood-ratio method was conducted to determine factors that could significantly
predict adherence as well as blood pressure control. Correlation and Hosmer-Lemeshow
Goodness-of-Fit Tests were done to select best prediction model.
Results
Demographics and health status
A total of 204 patients participated in the study. More than half of the sampled patients
(71.6%) were females with an overall mean age of 59.1 (SD = ± 12.21). The majority of the
study population was Saudis (93.1%), married (76%), and literate (48%). Most of the patients
132 (64.7%) were obese (BMI; 30 kg/m2) and only 15 patients (7.4%) had normal body mass
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index (BMI; 18.5 to 24.9 kg/m2). Of the 204 hypertensive patients sampled, 146 (71.6%) had
concomitant diabetes and 93 (45.6%) had hyperlipidemia (Table 1).
Adherence rate
Adherence scores ranged from 0 to 8 on MMAS-8. Based on the MMAS-8 score, patients were
categorized into three groups as described in the methods section: low adherence (MMAS-8
score < 6), medium adherence (MMAS-8 score 6 to< 8) or high adherence (MMAS-8 score
8). The frequency distribution is shown in Table 2. More than half of the respondents (54%)
had low adherence, while 23.5% and 22.5% had medium and high adherence level respectively.
Responses for each of the MMAS-8 are summarized in Table 3.
For the purpose of analysis, patients were classified in to two (adherent and non-adherent)
rather than three categories (low, medium, high) based on MMAS-8 scores: non-adherent
(MMAS-8 score < 6) and adherent (MMAS-8 score 6).
Table 4 shows results of the binary logistic regression analysis identifying the factors predict-
ing medication adherence. The model can explain 14% of the change in the adherence level
(P = 0.004). The odds of adherence for female patients are 60% less than the male patients (OR
0.40 [95% CI: 0.2–0.8; P = 0.01]). Patients aged> 65 years have twice the odds of medication
adherence compared to patients less than 65 years old (OR 2.0 [95% CI: 1.0–4.2; P = 0.04]).
Non-diabetic patients are 74% less likely to be adherent compared to diabetic patients (OR 0.2
[95% CI: 0.1–0.6; P = 0.04]).
Blood pressure control
Blood pressure control was better among patients with high level of adherence than those with
low adherence rate. Table 5 summarizes the predictors of blood pressure control using the
binary logistic regression. About 13.6% of the change in blood pressure can be explained by
this model (P = 0.002). The results showed that the odds of blood pressure control for over-
weight patients was 53% less than normal weight patient, (OR 0.4 [95% CI: 0.2–0.9; P = 0.03])
after adjusting for gender, age, and level of adherence. In addition, patients highly adherent to
their medications are five times more likely to have controlled blood pressure compared to low
adherent patients. (OR 4.9 [95% CI: 1.8–12.9; P = 0.001]) after adjusting for other
confounders.
Discussion
The aim of current study was to assess the extent of medication adherence among adult hyper-
tensive patients in the primary care setting. Identifying patient groups which are likely to have
poor blood pressure control is crucial for both clinicians and health policy makers so that
appropriate interventions targeting specifically these patient groups can be designed and
implemented. The present study was designed to build on earlier studies which have docu-
mented poor blood pressure control among Saudi patients by identifying factors affecting
blood pressure control and medication adherence [18–20, 24].
The current study found that the majority of the sampled hypertensive patients had low lev-
els of medication adherence. Poor adherence to antihypertensive medications is not only asso-
ciated with poor blood pressure control but also accelerates development of hypertension
related complications and increases hospital admissions rate [5,13,14]. In line with the findings
of our study, another local study conducted in Riyadh, Saudi Arabia among patients with long
term conditions also reported low levels of medication adherence among patients [24]. Various
international studies [6, 7, 25, 27], have also documented similar poor adherence rates which is
concerning given the negative consequences associated with non-adherence.
Medication Adherence and BP Control in Hypertensive Patients
PLOS ONE | DOI:10.1371/journal.pone.0171255 January 30, 2017 4 / 12
Table 1. Patients’ demographics and health status.
Demographic variables Total study population (N = 204)
N %
Gender
Female 146 71.6
Male 58 28.4
Age Mean (SD) 59.1 (12.2)
19–35 5 2.5
36–50 47 23
51–65 103 50.5
66–85 41 20.1
>85 8 3.9
BMI
Normal 15 7.4
Overweight 57 27.9
Obese 132 64.7
Level of Education
Illiterate 98 48
Elementary 46 22.5
High school 35 17.2
BS degree or higher 25 12.3
Nationality
Saudi 190 93.1
Non-Saudi 14 6.9
Employment status
Employed 33 16.2
Unemployed 130 63.7
Retired 41 20.1
Income status
Satisfied 160 78.4
Unsatisfied 44 21.6
Marital status
Single 17 8.3
Married 14 6.9
Divorced 95 46.6
Widowed 78 38.2
Number of children
No children 17 8.3
1–2 14 6.9
3–5 95 46.6
> 5 78 38.2
Smoking status
Smoking 25 12.3
Non-smoking 179 87.7
Number of comorbidities
 2 98 48
3 93 45.6
 4 13 6.4
Specific comorbidity
(Continued )
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The overall percentage of adherent patients in current study was less than the adherence
rate previously reported in Saudi Arabia. Previous studies have estimated adherence rates
between 35% and 53% [18–20]. The difference in the percentages of adherence rate between
the literature and current study may be related to the difference in the study population,
patients’ knowledge, health literacy, and complexity of patients’ regimens and health
conditions.
In the present study, gender, age and history of diabetes were found to be independent pre-
dictors associated with higher medication adherence rates. A number of local and interna-
tional studies have studied gender differences in relation to medication adherence and
reported inconsistent results [18–20, 24, 27]. Low levels of medication adherence among
female patients have been reported in this study and in a couple of other studies conducted in
Saudi Arabia [18, 20]. It has been documented that women with long term conditions are less
likely to receive medical treatment and monitoring as recommended by clinical guidelines
[28]. Lack of adequate monitoring may partly explain low levels of medication adherence
among females.
Table 1. (Continued)
Demographic variables Total study population (N = 204)
N %
Patients with DM 146 71.6
Patients with HF 2 1
Patient with Hyperlipidemia 93 45.6
Number of current medications Mean 4.4 (1.89)
1 10 4.9
2 25 12.3
3 34 16.7
4 48 23.5
5 34 16.7
6 53 25.9
Blood Pressure
Controlled 142 69.6
Uncontrolled 62 30.4
Abbreviations: N, number of patients; SD, standard deviation; BMI, Body mass index; DM, diabetes
mellitus; HF, heart failure.
doi:10.1371/journal.pone.0171255.t001
Table 2. Adherence level among hypertensive patients stratified by blood pressure control.
Adherence level (score) Blood pressure Total study population (N = 204)
N % Total (%)
Low adherence (< 6) Controlled 67 32.8 110 (54)
Uncontrolled 43 21.1
Medium adherence (6 to <8) Controlled 35 17.2 48 (23.5)
Uncontrolled 13 6.4
High adherence (= 8) Controlled 40 19.6 46 (22.5)
Uncontrolled 6 2.9
Abbreviations: N, number of patients.
doi:10.1371/journal.pone.0171255.t002
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Patients’ age was positively associated with the adherence score in this study and other
international studies [6, 19, 24, 26, 27]. For instance, one of the studies which was conducted
in Saudi Arabia, reported better adherence rate among hypertensive aged over 55 years than
those younger than 55 years (48.5% versus 26.2%, P < 0.001) [19]. Higher medication adher-
ence among older patients can be explained by the presence of a caregiver who would help
them in taking their medications. Furthermore, middle aged patients usually have work related
commitments and other priorities in their lives, therefore may not be able to attend their clinic
appointments and take their medicines as prescribed [29].
In line with the findings of previous studies [6–8, 11, 12, 18–21], medication adherence
was found to be an independent predictor of blood pressure control. In literature, a number of
factors affecting medication adherence, and subsequently therapeutic outcomes, have been
identified and are classified into: patient-related factors (e.g. socio-demographic factors, indi-
vidual’s knowledge and skills, individual’s beliefs and perceptions, and physical/mental abil-
ity), health system-related factors (e.g. quality of healthcare services, cost of treatment and
patient resources), and provider-related factors (e.g. provider-patient relationship and com-
munication) [5,30].
Another predictor of blood pressure control found in the present study was BMI, with nor-
mal weight patients had better BP control compared to overweight patients. Several studies
have reported positive impact of lifestyle modifications such as weight reduction, healthful die-
tary plan, regular physical activity and other behavioral changes on not only reducing systolic
and diastolic blood pressure but also on preventing complications associated with hyperten-
sion [4,5,17,31]. Therefore, physicians should educate patients about the benefits of healthy life
style and encourage lifestyle modifications, if required, especially weight reduction and smok-
ing cessation.
Mixed results have been reported regarding the association between number of medications
and adherence level [6–8, 19, 24, 27, 32, 33]. In another study conducted in Saudi Arabia,
patients with chronic diseases, multiple medications and complex regimens were more likely
to adhere to their long-term medications [24]. However, the present study could not find any
Table 3. Responses for each question in the (MMAS-8) scale.
Questions Total study population (N = 204)
Yes (%) No (%)
1. Do you sometimes forget to take your hypertension medication(s)? 90 (44.1) 114 (55.9)
2. People sometimes miss taking their medications for reasons other than forgetting. Thinking over the past
two weeks, were there any days when you did not take your hypertension medication(s)?
62 (30.4) 142 (69.6)
3. Have you ever cut back or stopped taking your medication(s) without telling your doctor, because you felt
worse when you took it?
49 (24) 155 (76)
4. When you travel or leave home, do you sometimes forget to bring along your hypertension medication(s)? 61 (29.9) 143 (70.1)
5. Did you take your medication(s) yesterday? 18 (8.8) 186 (91.2)
6. When you feel like your blood pressure is under control, do you sometimes stop taking your medication
(s)?
37 (18.1) 167 (81.9)
7. Taking medication(s) every day is a real inconvenience for some people. Do you ever feel hassled about
sticking to your hypertension treatment plan?
111 (54.4) 93 (45.6)
8. How often do you have difficulty remembering to take all your medication(s)? All the time Never/ Rarely Sometimes Once in a while Never/ Rarely
0 (0) 90 (44.1) 50 (24.5) 63 (30.9) 90 (44.1)
Abbreviations: MMAS-8, Morisky Medication Adherence Scale (8-item); N, number of patients. Notes: Use of the MMAS is protected by US copyright
laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community
Health Sciences, UCLA Fielding School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095–1772, dmorisky@ucla.edu.
doi:10.1371/journal.pone.0171255.t003
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association between number of medications and adherence level. The impact of poor adher-
ence rate on developing of hypertension-related complications was out of the scope of the
present study. However, one Saudi study has reported a positive impact of adherence on pre-
venting hypertension-related complications [18]. The study presented significantly less com-
plications among patients with fair-to-good compliance compared to those with poor
compliance [18].
Implications for clinical practice
The study findings have significant implications for controlling BP in primary care settings in
Saudi Arabia. A clear need to design and implement interventions to improve adherence
among hypertensive patients has been recognized. Furthermore, specific groups of patients
which are likely to be non-adherent (females, patients age < 65 years, widows) have also been
identified. Improving patients’ poor adherence to the antihypertensive medications could be
achieved by improving their knowledge, motivation, skills and resources to follow physicians
and/or other healthcare providers’ recommendations [7, 8, 18, 25, 26]. For instance, some of
the supporting interventions to increase patients’ adherence include: advising the patient to
record his/her medicine-taking, encouraging the patient to monitor his/her blood pressure
and other hypertension-related complications, simplifying the dosing regimen by the health-
care providers, and finally, providing annual review of care to the patient could help in im-
proving the adherence rate and the control of his/her blood pressure [2].
Table 4. Binary logistic regression analysis for factors predicting medication adherence.
Parameter Non-Adherent N (%) Adherent N (%) OR 95% CI for OR Lower—Upper P-value
Marital status
Widow 22 (69) 10 (31) 1
Single 2 (40) 3 (60) 2.55 0.3–19.8 0.36
Married 79 (51) 76 (49) 2.74 1.0–7.0 0.03*
Divorced 7 (58) 5 (42) 2.16 0.5–9.1 0.29
Diabetes
Diabetic 86 (59) 60 (41) 1
Non-diabetic 24 (41) 34 (59) 0.26 0.1–0.6 0.04*
Gender
Male 23 (40) 35 (60) 1
Female 87 (59) 59 (41) 0.40 0.2–0.8 0.01*
Age
 65 89 (57) 66 (43) 1
> 65 21 (43) 28 (57) 2.12 1.0–4.2 0.04*
Number of comorbidities
3 84 (53) 76 (47) 1
>3 26 (59) 18 (41) 1.11 0.3–3.6 0.91
Number of medications
>6 36 (52) 33 (48) 1
4–6 55 (53) 48 (47) 1.22 0.2–5.4 0.78
3 19 (59) 13 (41) 1.11 0.1–11.9 0.89
Notes: x2 = 22.65; df = 7; N = 204; P = 0.004; R2 = 0.139. Abbreviations: N, number of patients; CI, Confidence Interval; OR, Odds ratio; df, degrees of
freedom.
* indicates statistically significant results.
doi:10.1371/journal.pone.0171255.t004
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There are some limitations of current study. Firstly, the use of self-reported questionnaires
may under or over-reported the true incidence of patients’ poor adherence. Furthermore,
questionnaires are inherent to recall bias. There are a number of methods of assessing medica-
tion adherence (patient interviews, diaries, questionnaires, pill count, and pharmacy refills and
claims data) and no single method is perfect [34]. Therefore, triangulation of two methods is
recommended, if possible [34]. MMAS-8 was used in the present study as it is one the most
widely used self-reported measure to assesses medication adherence which allowed the authors
to compare their findings with the findings of other studies both locally and internationally.
Secondly, the study didn’t take into consideration the chronicity of hypertension and consider
it as one of the confounders. In addition, impact of other patient-related factors such as: pa-
tients’ knowledge and background, their beliefs and perception about their disease and treat-
ment, and their physical/mental ability should be evaluated in future research [30]. This will be
an important area for future research because health behavior researchers have provided evi-
dence that patients’ ideas about their diseases and medications is one of the predictors of medi-
cation adherence [25, 26, 30].
Conclusion
Adherence to medications is alarmingly low among hypertensive patients attending primary
care clinics in Makkah, Saudi Arabia. This calls for a well-designed educational intervention
especially targeting high risk groups (females, patients’ age< 65 years and widows). Since
non-adherence has been associated with increased hospitalizations and hypertension-related
complications, it is important to educate patients about the importance of medication adher-
ence. Barriers to medication adherence should also be explored among patients attending pri-
mary care clinics in Saudi Arabia. Without optimizing the use of medicines through patient-
professional partnership, it will be unlikely to achieve desired clinical outcomes for Saudi
patients.
Table 5. Binary logistic regression analysis identifying factors predicting BP control.
Predictor variables Blood pressure N (%) OR 95% CI for OR Lower—Upper P-value
Controlled Uncontrolled
Gender
Male 41(71) 17 (29) 1
Female 101 (69) 45 (31) 1.21 0.5 2.4 0.59
Age
 65 112 (72) 43 (28) 1
> 65 30 (61) 19 (39) 0.50 0.2 1.0 0.05
BMI
Normal weight 8 (5.6) 7 (11.3) 1
Overweight 35 (24.6) 22 (35.5) 0.47 0.2 0.9 0.03*
Obese 99 (69.7) 33 (53.2) 0.31 0.09 1.0 0.05
Level of adherence
Low adherence 67 (61) 43 (39) 1
Medium adherence 35 (73) 13 (27) 1.96 0.9 4.2 0.10
High adherence 40 (87) 6 (13) 4.90 1.8 12.9 0.001*
Notes: x2 = 20.590; df = 6; N = 204; P = 0.002; R2 = 0.136; Odds ratios are non-standardized. Abbreviations: BP, blood pressure; n, number of patients;
CI, confidence interval; OR, odds ratio; df, degrees of freedom; N, number of patients.
*donates statistically significance.
doi:10.1371/journal.pone.0171255.t005
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